Eye drop trial aims to halt blinding eye disease
Disease control
Recruiting now
This study is testing whether a new eye drop medication, GAL-101, can slow the progression of geographic atrophy, a form of age-related macular degeneration that causes permanent vision loss. About 110 participants will be randomly assigned to use either the active eye drops or a…
Phase: PHASE2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC